(Q42011164)

15 October 2017

Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia (English)

1 reference

15 October 2017

0 references

1 reference

Chris Kenyon

1

0 references

Karen Cohen

object named as

Karen Cohen

series ordinal

5

0 references

Robert Colebunders

series ordinal

4

object named as

Robert Colebunders

1 reference

15 October 2017

Sipho Mfolozi

2

1 reference

15 October 2017

Roland Croxford

series ordinal

3

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

British Journal of Clinical Pharmacology

15 October 2017

1 reference

15 October 2017

74

1 reference

15 October 2017

6

1 reference

15 October 2017

1070-1072

1 reference

Toxic leukoencephalopathies

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

A systematic review of the psychiatric side-effects of efavirenz

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

"Chasing the dragon"--heroin-associated spongiform leukoencephalopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Efavirenz in the therapy of HIV infection.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522823

10.1111/J.1365-2125.2012.04299.X

17 August 2018

Identifiers

DOI

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

22509819

1 reference